These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 28557171)

  • 1. Efficacy and feasibility of antidepressants for the prevention of migraine in adults: a meta-analysis.
    Xu XM; Yang C; Liu Y; Dong MX; Zou DZ; Wei YD
    Eur J Neurol; 2017 Aug; 24(8):1022-1031. PubMed ID: 28557171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tricyclic antidepressants for preventing migraine in adults.
    Xu XM; Liu Y; Dong MX; Zou DZ; Wei YD
    Medicine (Baltimore); 2017 Jun; 96(22):e6989. PubMed ID: 28562550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and feasibility of antidepressant treatment in patients with post-stroke depression.
    Xu XM; Zou DZ; Shen LY; Liu Y; Zhou XY; Pu JC; Dong MX; Wei YD
    Medicine (Baltimore); 2016 Nov; 95(45):e5349. PubMed ID: 27828858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, Safety, and Acceptability of Pharmacologic Treatments for Pediatric Migraine Prophylaxis: A Systematic Review and Network Meta-analysis.
    Locher C; Kossowsky J; Koechlin H; Lam TL; Barthel J; Berde CB; Gaab J; Schwarzer G; Linde K; Meissner K
    JAMA Pediatr; 2020 Apr; 174(4):341-349. PubMed ID: 32040139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of antidepressants in the treatment of adolescents and young adults with depression and substance use disorders: a systematic review and meta-analysis.
    Zhou X; Qin B; Del Giovane C; Pan J; Gentile S; Liu Y; Lan X; Yu J; Xie P
    Addiction; 2015 Jan; 110(1):38-48. PubMed ID: 25098732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic treatment of migraine in children: a systematic review of medication trials.
    Damen L; Bruijn JK; Verhagen AP; Berger MY; Passchier J; Koes BW
    Pediatrics; 2005 Aug; 116(2):e295-302. PubMed ID: 16061583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
    Dodick DW; Turkel CC; DeGryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF;
    Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tonabersat for migraine prophylaxis: a systematic review.
    Cao Y; Zheng OJ
    Pain Physician; 2014; 17(1):1-8. PubMed ID: 24452641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antidepressants in migraine prophylaxis].
    Nagata E
    Brain Nerve; 2009 Oct; 61(10):1131-4. PubMed ID: 19882939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate in Migraine Prevention: A 2016 Perspective.
    Silberstein SD
    Headache; 2017 Jan; 57(1):165-178. PubMed ID: 27902848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 1: amitriptyline.
    Lampl C; Versijpt J; Amin FM; Deligianni CI; Gil-Gouveia R; Jassal T; MaassenVanDenBrink A; Ornello R; Paungarttner J; Sanchez-Del-Rio M; Reuter U; Uluduz D; de Vries T; Zeraatkar D; Sacco S
    J Headache Pain; 2023 Apr; 24(1):39. PubMed ID: 37038134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of antidepressants in inflammatory arthritis: a Cochrane systematic review.
    Richards BL; Whittle SL; van der Heijde DM; Buchbinder R
    J Rheumatol Suppl; 2012 Sep; 90():21-7. PubMed ID: 22942325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
    Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of levetiracetam for migraine prophylaxis: A systematic review and meta-analysis.
    Yen PH; Kuan YC; Tam KW; Chung CC; Hong CT; Huang YH
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 3):755-764. PubMed ID: 32861551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressants in long-term migraine prevention.
    Koch HJ; Jürgens TP
    Drugs; 2009; 69(1):1-19. PubMed ID: 19192933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.